Investors & Partners
CEPI was founded in Davos by the governments of Norway and India, the Bill & Melinda Gates Foundation, the Wellcome Trust, and the World Economic Forum.
CEPI has secured $740 million toward its $1billion funding target, with multi-year funding from Norway, Germany, Japan, Canada, the Bill & Melinda Gates Foundation, and Wellcome. CEPI has also received single-year investments from the governments of Australia and Belgium. The European Commission foresees substantial financial contributions to support relevant projects through its mechanisms.
Close collaboration with global partners is also crucial to the success of our work to develop vaccines against emerging infectious diseases. That’s why work with industry, regulators, and other bodies to ensure that any vaccines we develop get licensed and can reach the people who need them.
Invest now
Investors Council
All investors contributing to CEPI’s funding pool are invited to join our Investors Council. The council nominates Investor representatives to the Board and has some rights including approval any single investments over $100 m.
Each investor appoints one person to represent them on the Investors Council, serving as members for the duration of their pledged commitment.
The Investors Council receives regular updates from the CEPI team, shares information with CEPI and each other, provides guidance and oversight of CEPI activities, and engages in resource mobilisation efforts.
Four members of the CEPI Investors Council serve on the CEPI Board, as part of the Executive and Investment Committee.
CEPI launches at 2017 Davos Meeting
Terms of reference